IPP Improvements—Recent Innovations, Current Iterations, and Developments in the Pipeline

Author(s): Engy Habashy, MD; Raevti Bole, MD; Sevann Helo, MD

JOURNAL

The Journal of Sexual Medicine

YEAR

2022

DOI

https://doi.org/10.1016/j.jsxm.2022.04.011

View on Publisher Site

Abstract Short Summary

This article highlights recent innovations and future developments in inflatable penile prostheses (IPPs), including Rigicon’s Infla10®, and compares current device offerings globally.

Abstract

Objective:

To review the current state, historical development, and future directions of inflatable penile prosthesis (IPP) technology.

Key Findings:

The article presents a comparative overview of IPPs from multiple manufacturers, including Rigicon’s Infla10®, noting global regulatory differences and the role of innovation in shaping functionality and user satisfaction. While U.S. approvals are limited to two companies, Rigicon is active in other markets and is part of the innovation pipeline pushing device evolution.

Conclusion:

Advances in IPP technology aim to optimize surgical outcomes, user experience, and durability. Companies like Rigicon contribute to this innovation landscape, even beyond the U.S. regulatory environment.

Clinical Relevance:

This review is relevant for clinicians seeking to stay updated on global developments in IPP design and performance, offering insights into current options and emerging technologies in prosthetic urology.

Keywords

inflatable penile prosthesis Infla10 Rigicon erectile dysfunction IPP innovation prosthetic urology penile implants Peyronie’s disease

This publication is available through the external link above. See the abstract for a summary of the research.

Back to Clinical Evidence